A Comprehensive Review of the Endometrial Receptivity Array in Euploid Embryo Transfer Cycles.

Autor:	Sharma M; Obstetrics and Gynaecology, All India Institute of Medical Sciences, Rajkot, IND., Dubey P; Obstetrics and Gynaecology, All India Institute of Medical Sciences, Rajkot, IND., Sunda U; Obstetrics and Gynaecology, All India Institute of Medical Sciences, Rajkot, IND., Tilva H; Obstetrics and Gynaecology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.; Obstetrics and Gynaecology, All India Institute of Medical Sciences, Rajkot, IND.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2024 Jun 26; Vol. 16 (6), pp. e63173. Date of Electronic Publication: 2024 Jun 26 (Print Publication: 2024).
DOI:	10.7759/cureus.63173
Abstrakt:	The Endometrial Receptivity Array (ERA) is a revolutionary molecular diagnostic tool that determines the optimal timing for embryo transfer by analyzing the gene expression profile of endometrial tissue. This comprehensive review examines the significance and application of ERA in euploid embryo transfer cycles, where the implantation of embryos with the correct number of chromosomes is critical for achieving successful pregnancy outcomes. This review underscores its role in enhancing implantation rates and reducing pregnancy loss by assessing the evolution, methodology, clinical applications, efficacy, and challenges associated with ERA. Key findings highlight ERA's superior accuracy in identifying the window of implantation compared to traditional methods, resulting in improved clinical outcomes in assisted reproductive technology (ART) cycles. Despite its benefits, the review acknowledges challenges such as cost, accessibility, and the need for standardization. Recommendations for clinical practice emphasize the integration of ERA into routine ART protocols, comprehensive patient counseling, and the importance of multidisciplinary collaboration. The review outlines promising prospects, including technological advancements to make ERA more cost-effective, the development of refined gene expression profiles, and the potential integration with other emerging ART technologies. Further research directions include long-term studies on the outcomes of ERA-guided pregnancies and exploring its application in cases of recurrent implantation failure and unexplained infertility. Overall, ERA represents a significant advancement in reproductive medicine, offering a personalized approach to embryo transfer timing that can significantly improve the success rates of euploid embryo transfers. Competing Interests: Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work. (Copyright © 2024, Sharma et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu